カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

豚流行性下痢ワクチンの世界市場2025年：生ワクチン、不活化ワクチン

■ 英語タイトル：Global Porcine Epidemic Diarrhea Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3900）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3900
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[豚流行性下痢ワクチンの世界市場2025年：生ワクチン、不活化ワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の豚流行性下痢ワクチン市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の豚流行性下痢ワクチンの市場規模は2024年のxxx米ドルから2031年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

豚流行性下痢ワクチン市場はタイプとアプリケーションによって区分されます。2020年～2031年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・生ワクチン、不活化ワクチン

アプリケーション別セグメントは次のように区分されます。
・子豚用、成豚用

世界の豚流行性下痢ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・CAVAC、Green Cross Veterinary Products、Harrisvaccines、Komipharm、Nisseiken、Qilu Animal Health、Zoetis

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、豚流行性下痢ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な豚流行性下痢ワクチンメーカーの企業概要、2022年～2024年までの豚流行性下痢ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な豚流行性下痢ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2020年～2031年までの地域別豚流行性下痢ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2020年～2031年までの豚流行性下痢ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2020年～2024年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での豚流行性下痢ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および豚流行性下痢ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、豚流行性下痢ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 豚流行性下痢ワクチンの概要
– 種類別分析（2020年vs2024年vs2031年）：生ワクチン、不活化ワクチン
– 用途別分析（2020年vs2024年vs2031年）：子豚用、成豚用
– 世界の豚流行性下痢ワクチン市場規模・予測
– 世界の豚流行性下痢ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– CAVAC、Green Cross Veterinary Products、Harrisvaccines、Komipharm、Nisseiken、Qilu Animal Health、Zoetis
・メーカー別市場シェア・市場集中度
・地域別市場分析2020年-2031年
・種類別分析2020年-2031年：生ワクチン、不活化ワクチン
・用途別分析2020年-2031年：子豚用、成豚用
・豚流行性下痢ワクチンの北米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・豚流行性下痢ワクチンのヨーロッパ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・豚流行性下痢ワクチンのアジア市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・豚流行性下痢ワクチンの南米市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・豚流行性下痢ワクチンの中東・アフリカ市場
– 種類別市場規模2020年-2031年
– 用途別市場規模2020年-2031年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Porcine Epidemic Diarrhea Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Porcine Epidemic Diarrhea Vaccines Revenue by Type: 2020 Versus 2024 Versus 2031
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Porcine Epidemic Diarrhea Vaccines Revenue by Application: 2020 Versus 2024 Versus 2031
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Global Porcine Epidemic Diarrhea Vaccines Market Size & Forecast
1.4.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Value (2020 & 2024 & 2031)
1.4.2 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume (2020-2031)
1.4.3 Global Porcine Epidemic Diarrhea Vaccines Price (2020-2031)
1.5 Global Porcine Epidemic Diarrhea Vaccines Production Capacity Analysis
1.5.1 Global Porcine Epidemic Diarrhea Vaccines Total Production Capacity (2020-2031)
1.5.2 Global Porcine Epidemic Diarrhea Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Porcine Epidemic Diarrhea Vaccines Market Drivers
1.6.2 Porcine Epidemic Diarrhea Vaccines Market Restraints
1.6.3 Porcine Epidemic Diarrhea Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 CAVAC
2.1.1 CAVAC Details
2.1.2 CAVAC Major Business
2.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
2.1.4 CAVAC Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.2 Green Cross Veterinary Products
2.2.1 Green Cross Veterinary Products Details
2.2.2 Green Cross Veterinary Products Major Business
2.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
2.2.4 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.3 Harrisvaccines
2.3.1 Harrisvaccines Details
2.3.2 Harrisvaccines Major Business
2.3.3 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
2.3.4 Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.4 Komipharm
2.4.1 Komipharm Details
2.4.2 Komipharm Major Business
2.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
2.4.4 Komipharm Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.5 Nisseiken
2.5.1 Nisseiken Details
2.5.2 Nisseiken Major Business
2.5.3 Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
2.5.4 Nisseiken Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.6 Qilu Animal Health
2.6.1 Qilu Animal Health Details
2.6.2 Qilu Animal Health Major Business
2.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
2.6.4 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
2.7 Zoetis
2.7.1 Zoetis Details
2.7.2 Zoetis Major Business
2.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
2.7.4 Zoetis Porcine Epidemic Diarrhea Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2021, 2022, 2023, and 2024)
3 Porcine Epidemic Diarrhea Vaccines Breakdown Data by Manufacturer
3.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Manufacturer (2021, 2022, 2023, and 2024)
3.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturer (2021, 2022, 2023, and 2024)
3.3 Key Manufacturer Market Position in Porcine Epidemic Diarrhea Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Porcine Epidemic Diarrhea Vaccines Manufacturer Market Share in 2024
3.4.2 Top 6 Porcine Epidemic Diarrhea Vaccines Manufacturer Market Share in 2024
3.5 Global Porcine Epidemic Diarrhea Vaccines Production Capacity by Company: 2023 VS 2024
3.6 Manufacturer by Geography: Head Office and Porcine Epidemic Diarrhea Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Porcine Epidemic Diarrhea Vaccines Market Size by Region
4.1.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2020-2031)
4.1.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2020-2031)
4.2 North America Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031)
4.3 Europe Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031)
4.4 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031)
4.5 South America Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031)
4.6 Middle East and Africa Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031)
5 Market Segment by Type
5.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Type (2020-2031)
5.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2020-2031)
5.3 Global Porcine Epidemic Diarrhea Vaccines Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Porcine Epidemic Diarrhea Vaccines Sales in Volume by Application (2020-2031)
6.2 Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2020-2031)
6.3 Global Porcine Epidemic Diarrhea Vaccines Price by Application (2020-2031)
7 North America by Country, by Type, and by Application
7.1 North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2031)
7.2 North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2031)
7.3 North America Porcine Epidemic Diarrhea Vaccines Market Size by Country
7.3.1 North America Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2020-2031)
7.3.2 North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe by Country, by Type, and by Application
8.1 Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2031)
8.2 Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2031)
8.3 Europe Porcine Epidemic Diarrhea Vaccines Market Size by Country
8.3.1 Europe Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2020-2031)
8.3.2 Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2031)
9.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2031)
9.3 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Market Size by Region
9.3.1 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales in Volume by Region (2020-2031)
9.3.2 Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America by Region, by Type, and by Application
10.1 South America Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2031)
10.2 South America Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2031)
10.3 South America Porcine Epidemic Diarrhea Vaccines Market Size by Country
10.3.1 South America Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2020-2031)
10.3.2 South America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2031)
11.2 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2031)
11.3 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Market Size by Country
11.3.1 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales in Volume by Country (2020-2031)
11.3.2 Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Raw Material and Industry Chain
12.1 Raw Material of Porcine Epidemic Diarrhea Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Porcine Epidemic Diarrhea Vaccines
12.3 Porcine Epidemic Diarrhea Vaccines Production Process
12.4 Porcine Epidemic Diarrhea Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Porcine Epidemic Diarrhea Vaccines Typical Distributors
13.3 Porcine Epidemic Diarrhea Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Porcine Epidemic Diarrhea Vaccines Revenue by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Porcine Epidemic Diarrhea Vaccines Revenue by Application, (USD Million), 2020 & 2024 & 2031
Table 3. CAVAC Basic Information, Manufacturing Base and Competitors
Table 4. CAVAC Major Business
Table 5. CAVAC Porcine Epidemic Diarrhea Vaccines Product and Services
Table 6. CAVAC Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 7. Green Cross Veterinary Products Basic Information, Manufacturing Base and Competitors
Table 8. Green Cross Veterinary Products Major Business
Table 9. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Product and Services
Table 10. Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 11. Harrisvaccines Basic Information, Manufacturing Base and Competitors
Table 12. Harrisvaccines Major Business
Table 13. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Product and Services
Table 14. Harrisvaccines Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 15. Komipharm Basic Information, Manufacturing Base and Competitors
Table 16. Komipharm Major Business
Table 17. Komipharm Porcine Epidemic Diarrhea Vaccines Product and Services
Table 18. Komipharm Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 19. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 20. Nisseiken Major Business
Table 21. Nisseiken Porcine Epidemic Diarrhea Vaccines Product and Services
Table 22. Nisseiken Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 23. Qilu Animal Health Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Animal Health Major Business
Table 25. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Product and Services
Table 26. Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 27. Zoetis Basic Information, Manufacturing Base and Competitors
Table 28. Zoetis Major Business
Table 29. Zoetis Porcine Epidemic Diarrhea Vaccines Product and Services
Table 30. Zoetis Porcine Epidemic Diarrhea Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2021, 2022, 2023, and 2024)
Table 31. Global Porcine Epidemic Diarrhea Vaccines Sales by Manufacturer (2021, 2022, 2023, and 2024) & (K Units)
Table 32. Global Porcine Epidemic Diarrhea Vaccines Revenue by Manufacturer (2021, 2022, 2023, and 2024) & (USD Million)
Table 33. Market Position of Manufacturers in Porcine Epidemic Diarrhea Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 34. Global Porcine Epidemic Diarrhea Vaccines Production Capacity by Company, (K Units): 2023 VS 2024
Table 35. Head Office and Porcine Epidemic Diarrhea Vaccines Production Site of Key Manufacturer
Table 36. Porcine Epidemic Diarrhea Vaccines New Entrant and Capacity Expansion Plans
Table 37. Porcine Epidemic Diarrhea Vaccines Mergers & Acquisitions in the Past Five Years
Table 38. Global Porcine Epidemic Diarrhea Vaccines Sales by Region (2020-2024) & (K Units)
Table 39. Global Porcine Epidemic Diarrhea Vaccines Sales by Region (2025-2031) & (K Units)
Table 40. Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2020-2024) & (USD Million)
Table 41. Global Porcine Epidemic Diarrhea Vaccines Revenue by Region (2025-2031) & (USD Million)
Table 42. Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2024) & (K Units)
Table 43. Global Porcine Epidemic Diarrhea Vaccines Sales by Type (2025-2031) & (K Units)
Table 44. Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2020-2024) & (USD Million)
Table 45. Global Porcine Epidemic Diarrhea Vaccines Revenue by Type (2025-2031) & (USD Million)
Table 46. Global Porcine Epidemic Diarrhea Vaccines Price by Type (2020-2024) & (USD/Unit)
Table 47. Global Porcine Epidemic Diarrhea Vaccines Price by Type (2025-2031) & (USD/Unit)
Table 48. Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2024) & (K Units)
Table 49. Global Porcine Epidemic Diarrhea Vaccines Sales by Application (2025-2031) & (K Units)
Table 50. Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2020-2024) & (USD Million)
Table 51. Global Porcine Epidemic Diarrhea Vaccines Revenue by Application (2025-2031) & (USD Million)
Table 52. Global Porcine Epidemic Diarrhea Vaccines Price by Application (2020-2024) & (USD/Unit)
Table 53. Global Porcine Epidemic Diarrhea Vaccines Price by Application (2025-2031) & (USD/Unit)
Table 54. North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2020-2024) & (K Units)
Table 55. North America Porcine Epidemic Diarrhea Vaccines Sales by Country (2025-2031) & (K Units)
Table 56. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2020-2024) & (USD Million)
Table 57. North America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2025-2031) & (USD Million)
Table 58. North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2024) & (K Units)
Table 59. North America Porcine Epidemic Diarrhea Vaccines Sales by Type (2025-2031) & (K Units)
Table 60. North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2024) & (K Units)
Table 61. North America Porcine Epidemic Diarrhea Vaccines Sales by Application (2025-2031) & (K Units)
Table 62. Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2020-2024) & (K Units)
Table 63. Europe Porcine Epidemic Diarrhea Vaccines Sales by Country (2025-2031) & (K Units)
Table 64. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2020-2024) & (USD Million)
Table 65. Europe Porcine Epidemic Diarrhea Vaccines Revenue by Country (2025-2031) & (USD Million)
Table 66. Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2024) & (K Units)
Table 67. Europe Porcine Epidemic Diarrhea Vaccines Sales by Type (2025-2031) & (K Units)
Table 68. Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2024) & (K Units)
Table 69. Europe Porcine Epidemic Diarrhea Vaccines Sales by Application (2025-2031) & (K Units)
Table 70. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region (2020-2024) & (K Units)
Table 71. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Region (2025-2031) & (K Units)
Table 72. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2020-2024) & (USD Million)
Table 73. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue by Region (2025-2031) & (USD Million)
Table 74. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2024) & (K Units)
Table 75. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Type (2025-2031) & (K Units)
Table 76. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2024) & (K Units)
Table 77. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales by Application (2025-2031) & (K Units)
Table 78. South America Porcine Epidemic Diarrhea Vaccines Sales by Country (2020-2024) & (K Units)
Table 79. South America Porcine Epidemic Diarrhea Vaccines Sales by Country (2025-2031) & (K Units)
Table 80. South America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2020-2024) & (USD Million)
Table 81. South America Porcine Epidemic Diarrhea Vaccines Revenue by Country (2025-2031) & (USD Million)
Table 82. South America Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2024) & (K Units)
Table 83. South America Porcine Epidemic Diarrhea Vaccines Sales by Type (2025-2031) & (K Units)
Table 84. South America Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2024) & (K Units)
Table 85. South America Porcine Epidemic Diarrhea Vaccines Sales by Application (2025-2031) & (K Units)
Table 86. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Region (2020-2024) & (K Units)
Table 87. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Region (2025-2031) & (K Units)
Table 88. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Region (2020-2024) & (USD Million)
Table 89. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue by Region (2025-2031) & (USD Million)
Table 90. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2020-2024) & (K Units)
Table 91. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Type (2025-2031) & (K Units)
Table 92. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2020-2024) & (K Units)
Table 93. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales by Application (2025-2031) & (K Units)
Table 94. Porcine Epidemic Diarrhea Vaccines Raw Material
Table 95. Key Manufacturers of Porcine Epidemic Diarrhea Vaccines Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Porcine Epidemic Diarrhea Vaccines Typical Distributors
Table 99. Porcine Epidemic Diarrhea Vaccines Typical Customers
List of Figures
Figure 1. Porcine Epidemic Diarrhea Vaccines Picture
Figure 2. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type in 2024
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application in 2024
Figure 6. Piglets
Figure 7. Adults Pigs
Figure 8. Global Porcine Epidemic Diarrhea Vaccines Revenue, (USD Million) & (K Units): 2020 & 2024 & 2031
Figure 9. Global Porcine Epidemic Diarrhea Vaccines Revenue and Forecast (2020-2031) & (USD Million)
Figure 10. Global Porcine Epidemic Diarrhea Vaccines Sales (2020-2031) & (K Units)
Figure 11. Global Porcine Epidemic Diarrhea Vaccines Price (2020-2031) & (USD/Unit)
Figure 12. Global Porcine Epidemic Diarrhea Vaccines Production Capacity (2020-2031) & (K Units)
Figure 13. Global Porcine Epidemic Diarrhea Vaccines Production Capacity by Geographic Region: 2024 VS 2031
Figure 14. Porcine Epidemic Diarrhea Vaccines Market Drivers
Figure 15. Porcine Epidemic Diarrhea Vaccines Market Restraints
Figure 16. Porcine Epidemic Diarrhea Vaccines Market Trends
Figure 17. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Manufacturer in 2024
Figure 18. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Manufacturer in 2024
Figure 19. Porcine Epidemic Diarrhea Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 20. Top 3 Porcine Epidemic Diarrhea Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Porcine Epidemic Diarrhea Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2020-2031)
Figure 23. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2020-2031)
Figure 24. North America Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031) & (USD Million)
Figure 25. Europe Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031) & (USD Million)
Figure 27. South America Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue (2020-2031) & (USD Million)
Figure 29. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2020-2031)
Figure 30. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2020-2031)
Figure 31. Global Porcine Epidemic Diarrhea Vaccines Price by Type (2020-2031) & (USD/Unit)
Figure 32. Global Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2020-2031)
Figure 33. Global Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2020-2031)
Figure 34. Global Porcine Epidemic Diarrhea Vaccines Price by Application (2020-2031) & (USD/Unit)
Figure 35. North America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2020-2031)
Figure 36. North America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2020-2031)
Figure 37. North America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2020-2031)
Figure 38. North America Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2020-2031)
Figure 39. United States Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 40. Canada Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 41. Mexico Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 42. Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2020-2031)
Figure 43. Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2020-2031)
Figure 44. Europe Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2020-2031)
Figure 45. Europe Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2020-2031)
Figure 46. Germany Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 47. France Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 48. United Kingdom Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 49. Russia Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 50. Italy Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2020-2031)
Figure 55. China Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 56. Japan Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 57. Korea Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 58. India Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 59. Southeast Asia Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 60. Australia Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 61. South America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2020-2031)
Figure 62. South America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2020-2031)
Figure 63. South America Porcine Epidemic Diarrhea Vaccines Sales Market Share by Country (2020-2031)
Figure 64. South America Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Country (2020-2031)
Figure 65. Brazil Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 66. Argentina Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Sales Market Share by Region (2020-2031)
Figure 70. Middle East & Africa Porcine Epidemic Diarrhea Vaccines Revenue Market Share by Region (2020-2031)
Figure 71. Turkey Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 72. Egypt Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 74. South Africa Porcine Epidemic Diarrhea Vaccines Revenue and Growth Rate (2020-2031) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Porcine Epidemic Diarrhea Vaccines in 2024
Figure 76. Manufacturing Process Analysis of Porcine Epidemic Diarrhea Vaccines
Figure 77. Porcine Epidemic Diarrhea Vaccines Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 豚伝染性胃腸炎、豚流行性下痢、豚ロタウイルスワクチンのグローバル市場2023：生ワクチン、不活化ワクチン
  • 豚繁殖性呼吸器症候群（PRRS）ワクチンの世界市場2025年：生ワクチン、不活化ワクチン
  • アフリカ馬疫ワクチンの世界市場2025年：生ワクチン、不活化ワクチン
  • 赤羽ワクチンの世界市場2025年：生ワクチン、不活化ワクチン
  • 青眼病ワクチンの世界市場2025年：生ワクチン、不活化ワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3900 )"豚流行性下痢ワクチンの世界市場2025年：生ワクチン、不活化ワクチン" (英文：Global Porcine Epidemic Diarrhea Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。